Immunomodulators - Part A
Elsevier (Publisher)
Published on 2. April 2026
488 pages
978-0-443-34522-7 (ISBN)
Description
Immodulators, Volume 151 explores the pivotal role immodulators play in regulating immune responses for health and disease management. The book provides an in-depth overview of various classes of immunomodulatory agents, including biologics, small molecules, natural compounds, and synthetic drugs, examining their mechanisms of action and therapeutic applications. Chapters in this new release include Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational Challenges, Advances in Immunomodulation: From Dietary Influence to Computational Precision, iPSC-derived immunotherapy for Tau and Alzheimer's disease, and much more.Additional sections cover Antibodies targeting amyloid-ß and Tau oligomers in Alzheimer's Disease, Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding Diseases, Immunomodulator drugs: mechanisms of action and systemic effects, Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancers, Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnata, Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics Approach, Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic Arthritis, and many additional topics.
- Covers the fundamental principles of immunomodulation and the mechanisms by which immunomodulators influence the immune system
- Provides a detailed discussion of various classes, including biological, synthetic, natural, and small molecule immunomodulators
- Explains how immunomodulators work at cellular and molecular levels to modulate immune responses
More details
Other editions
Additional editions
Person
Content
1. Marine-Derived Polysaccharides and Peptides as Next-Generation Immunomodulators: Molecular Mechanisms, Therapeutic Potential, and Translational ChallengesSelvaraj Chandrabose Sr.2. Advances in Immunomodulation: From Dietary Influence to Computational PrecisionKarthick Vasudevan, Prasanna Kumar Selvam and Supraja Mohan3. iPSC-derived immunotherapy for Tau and Alzheimer's diseaseSubashchandrabose Chinnathambi4. Antibodies targeting amyloid-ß and Tau oligomers in Alzheimer's DiseaseSubashchandrabose Chinnathambi5. Biosimilars: Antibody and Nanobody Based Therapeutic Approaches Towards Protein Misfolding DiseasesSubashchandrabose Chinnathambi and Nagaraj Rangappa6. Immunomodulator drugs: mechanisms of action and systemic effectsVijay Kumar Prajapati7. Microbiome and microbial products as immunomodulators: implication for gastrointestinal cancersVijay Kumar Prajapati8. Integration of Network pharmacology, docking, and dynamics analysis to investigate the immunomodulatory activity of Pongamia pinnataGeorge Priya Doss C9. Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A bioinformatics ApproachGeorge Priya Doss C, Mangesh R, Santhosh Elavarasu, Insha Asheem, Nihla M, Udhaya Kumar and Sasikumar K10. Utilizing DREIMT Database for Drug Prioritization in Immunomodulatory Therapy for Psoriasis and Psoriatic ArthritisGeorge Priya Doss C11. Targeting Immune Modulation Genes in Mpox. A Therapeutic Approach Using Natural CompoundsGeorge Priya Doss C12. Identification of Common Hub Genes and Pathways in Systemic Lupus Erythematosus and Cervical Cancer Using Bioinformatics ApproachGeorge Priya Doss C, Tamizhini Loganathan and Hatem Zayed13. Transcriptomic Profiling Reveals Immune Pathway Dysregulation and Key Interferon-Responsive Genes in Systemic Lupus ErythematosusKarthick Vasudevan, Prasanna Kumar Selvam and Supraja Mohan14. TBC*Edeildo Ferreira da Silva-Júnior15. TBC*Edeildo Ferreira da Silva-Júnior16. Synthetic Immunomodulators: Revolutionizing ImmunotherapyAjaz Ahmad Bhat17. Therapeutics Immunotargets for TauopathySubashchandrabose Chinnathambi18. Antioxidants as immunomodulators for Tau and Amyloid-ß in Alzheimer's diseaseSubashchandrabose Chinnathambi19. VISTA as a double-edged immune checkpoint molecule in cancer and autoimmunitySibel Kalyoncu Uzunlar
